Robotic Surgery Health Insurance Sub-Limit: What IRDAI 2024 Says

Personal Finance · Health Insurance · Quick answer 45 sec · Full read 10 min

Does IRDAI 2024 permit a robotic surgery health insurance sub-limit?

Yes — and the distinction between coverage and payout amount is the entire issue. The IRDAI Master Circular on Health Insurance Business, 29 May 2024, lists robotic surgery among the modern treatment methods that every indemnity health policy must include. An insurer cannot refuse a claim solely because the procedure was performed robotically. The procedure cannot be called experimental if it appears on the modern treatments list in the policy’s annexure.

What the circular does not do is fix the payment amount. Insurers remain free to apply a sub-limit — a ceiling — on what they will pay toward modern treatment costs, including robotic surgery. Public-sector insurers and many older private-sector plans impose these caps. A policy with a Rs 10 lakh sum insured may carry a Rs 3 lakh maximum for robotic surgery; the policyholder bears the remainder.

The distinction matters because the IRDAI parent article on health insurance rules acknowledged that sub-limit permission for modern treatments had not been verified against the circular’s annexure. This article closes that gap. The answer, consistent across secondary sources: sub-limits are permitted. The prohibition in the circular is specific to AYUSH — those treatments must be paid up to the full sum insured. Robotic surgery and other modern treatment methods do not carry that protection.

Two things the circular explicitly does not permit: rejecting the claim outright because surgery was robotic; and labelling the procedure experimental if it appears on the modern treatments list. Both grounds, if used, are grievable.

What your policy’s Modern Treatment schedule actually says

The Modern Treatment Benefits section of your policy schedule — usually a single page in the policy document — is the document that determines your actual exposure, not the insurer’s verbal assurance at renewal. What is said at the point of sale is not a term of the contract, which is the conduct problem the regulators have been working on from the other direction as well — see our note on the RBI rules on mis-selling and bundling. Every policy issued or renewed after the 2024 circular must name each covered modern treatment method and state the coverage terms. Robotic surgery will appear by name. The adjacent column shows either “up to sum insured” or a sub-limit figure.

Two line items on the same page often go unchecked:

Consumables and disposables. Robotic procedures use single-use components — disposable draping, instrument adapters, and in some systems the robotic arm tip itself — which appear as a separate line on the hospital bill. Policies issued before the 2024 circular frequently exclude “consumables” as a general category without carving out items listed under modern treatments. If your policy was issued before May 2024 and has not been renewed under the revised framework, the robotic procedure may be covered while the consumables cost — which can run to several lakhs for complex procedures — is excluded separately. Check whether your policy’s consumables exclusion contains an exception for modern treatment items.

Room rent interaction. If your policy carries a room rent sub-limit and you occupy a room above that limit, the insurer applies a proportionate deduction to the entire claim — including the robotic surgery component. A room-rent cap of Rs 4,000 per day against an actual room cost of Rs 8,000 means 50 percent of all eligible costs is deducted after the surgery sub-limit is applied. These two caps compound; they do not operate independently. This is the practical reason a headline sum insured overstates real cover, and why sizing health cover on the sum insured alone produces the wrong number.

One thing a sub-limit does not affect: the premium remains deductible under Section 80D of the Income-tax Act, 1961 (Section 126 of the Income-tax Act, 2025) if you file on the old regime. The deduction attaches to the premium paid, not to what the policy eventually pays out — see our income tax guide for salaried filers for the limits that apply.

When the insurer partially approves the claim: your options

The most effective tool is a Medical Necessity Letter from the operating surgeon, obtained before pre-authorisation is finalised — not after the claim is filed. The IRDAI 2024 circular requires insurers to respond to planned-procedure pre-authorisation requests within one hour. If the insurer pre-approves an amount that reflects a conventional laparoscopic benchmark rather than robotic surgery costs, you have time to dispute before the procedure begins.

The insurer’s “traditional cost” argument — that a standard laparoscopic procedure would have achieved equivalent outcomes at lower cost — is countered with clinical documentation. The Medical Necessity Letter from the surgeon should document specifically why robotic assistance was clinically required for this patient and this procedure: anatomical complexity, reduced risk of conversion, post-operative recovery expectations. It must establish medical necessity, not preference. Submit the letter with the pre-auth request and ask the insurer to revise the approved amount in writing before the surgery date.

If the claim is rejected on grounds of the procedure being experimental — which is not a valid ground if robotic surgery appears on the policy’s modern treatments list — the escalation sequence under IRDAI’s integrated grievance framework is: (1) file with the insurer’s internal grievance cell, which must acknowledge within three working days and resolve within 30 days; (2) if the response is unsatisfactory or no response within 30 days, file a complaint with the Insurance Ombudsman for the relevant region. Ombudsman orders are binding on insurers for claims up to Rs 30 lakh and are free of charge for the complainant. The same two-step architecture — the institution’s own grievance cell first, an ombudsman second — is what governs a disputed bank transaction on the RBI side.